Where Immunovant Stands With Analysts
Portfolio Pulse from Benzinga Insights
Immunovant (NASDAQ:IMVT) has received 8 analyst ratings in the last quarter, all of which are bullish to some extent. The average price target is $31.0, indicating potential upside from the current price of $21.715. This average price target has increased by 12.73% over the past month.
September 18, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Immunovant has received all bullish ratings from 8 analysts, indicating potential upside. The average price target has increased by 12.73% over the past month.
The all bullish ratings from analysts and the increase in the average price target over the past month indicate a positive outlook for Immunovant. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100